TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $119
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Ryan Langston has maintained a Buy rating on Addus HomeCare (NASDAQ:ADUS) and increased the price target from $105 to $119.
May 09, 2024 | 4:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TD Cowen reaffirms Buy rating on Addus HomeCare and raises price target to $119.
The upgrade in the price target by a reputable analyst like Ryan Langston from TD Cowen suggests a strong confidence in Addus HomeCare's future performance. This is likely to be viewed positively by investors, potentially leading to an increase in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100